Wesper Inc. — SEC Form D Filing

Wesper Inc. filed an SEC Form D on July 14, 2026, reporting $8.30M raised in Medical Devices.

Form D filing details

Filing
SEC Form D
Filing date
July 14, 2026
Amount reported
$8.30M
Round stage
Seed
Industry
Medical Devices
Website
https://wesper.co/

What the company does

Securities: Equity, Debt. Revenue: $1 - $1,000,000. Exemption: Rule 506(b). Incorporated: DELAWARE

Problem

Traditional home sleep tests often prioritize convenience over clinical precision, leading to uncomfortable patient experiences, signal loss, and limited apnea detection.

Solution

Wesper provides an at-home sleep testing ecosystem, including Wesper Lab (FDA-cleared HSAT with high-fidelity respiratory data) and Wesper Lite (PPG-based diagnostics), to offer clinically reliable data and personalized sleep care.

Why now

There is a growing demand for convenient and accurate home diagnostics due to advances in wearable technology and remote healthcare, alongside increasing awareness of sleep health issues.

Verdict

Investors backed Wesper's Seed round due to its FDA-cleared, high-fidelity at-home sleep apnea testing solution, betting on a clearer diagnostic pathway for a common condition. This cleared because the product offered a defensible clinical improvement on existing diagnostics, not because it promised novel treatment modalities or a broad digital health platform play. Upside was limited by the specialized regulatory pathway and the established, albeit imperfect, market for sleep diagnostics.

Source: SEC EDGAR Form D filing